Thomas W. Dubensky, JR.,Nancy A. Hosken,Scott H. Robbins,Margaret D. Moore
申请号：
US16513311
公开号：
US20200023057A1
申请日:
2019.07.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects.
